C4X Discovery Holdings (FRA:C4J) FCF Margin % : 36.18% (As of Jan. 2024)

View and export this data going back to 2020. Start your Free Trial

What is C4X Discovery Holdings FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. C4X Discovery Holdings's Free Cash Flow for the six months ended in Jan. 2024 was €10.40 Mil. C4X Discovery Holdings's Revenue for the six months ended in Jan. 2024 was €28.75 Mil. Therefore, C4X Discovery Holdings's FCF Margin % for the quarter that ended in Jan. 2024 was 36.18%.

As of today, C4X Discovery Holdings's current FCF Yield % is 15.07%.

The historical rank and industry rank for C4X Discovery Holdings's FCF Margin % or its related term are showing as below:

FRA:C4J' s FCF Margin % Range Over the Past 10 Years
Min: -4655.24 Med: -401.3 Max: 14.54
Current: 14.54

During the past 12 years, the highest FCF Margin % of C4X Discovery Holdings was 14.54%. The lowest was -4655.24%. And the median was -401.30%.

FRA:C4J's FCF Margin % is ranked better than
89.38% of 1045 companies
in the Biotechnology industry
Industry Median: -143.92 vs FRA:C4J: 14.54

C4X Discovery Holdings FCF Margin % Historical Data

The historical data trend for C4X Discovery Holdings's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

C4X Discovery Holdings FCF Margin % Chart

C4X Discovery Holdings Annual Data

Trend

Jul14

Jul15

Jul16

Jul17

Jul18

Jul19

Jul20

Jul21

Jul22

Jul23

FCF Margin %

Get a 7-Day Free Trial

-54.76

-449.14

-353.51

C4X Discovery Holdings Semi-Annual Data
	Jul14	Jan15	Jul15	Jan16	Jul16	Jan17	Jul17	Jan18	Jul18	Jan19	Jul19	Jan20	Jul20	Jan21	Jul21	Jan22	Jul22	Jan23	Jul23	Jan24
FCF Margin %	Get a 7-Day Free Trial															-8,517.72	-247.02	-42.44	-15,535.00	36.18

Competitive Comparison of C4X Discovery Holdings's FCF Margin %

For the Biotechnology subindustry, C4X Discovery Holdings's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

C4X Discovery Holdings's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, C4X Discovery Holdings's FCF Margin % distribution charts can be found below:

* The bar in red indicates where C4X Discovery Holdings's FCF Margin % falls into.

C4X Discovery Holdings FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

C4X Discovery Holdings's FCF Margin for the fiscal year that ended in Jul. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Jul. 2023 )	/	Revenue (A: Jul. 2023 )
	=	-7.042	/	1.992
	=	-353.51 %

C4X Discovery Holdings's FCF Margin for the quarter that ended in Jan. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Jan. 2024 )	/	Revenue (Q: Jan. 2024 )
	=	10.401	/	28.748
	=	36.18 %

C4X Discovery Holdings FCF Margin % Related Terms

Thank you for viewing the detailed overview of C4X Discovery Holdings's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

C4X Discovery Holdings (FRA:C4J) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » C4X Discovery Holdings PLC (FRA:C4J) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

C4XD:UK C4J:Germany

Address

53 Portland Street, Manchester One, Manchester, GBR, M1 3LD

Website

https://www.c4xdiscovery.com

C4X Discovery Holdings PLC is a drug discovery and development company. It has various proprietary and synergistic software platforms Taxonomy3, Conformetrix, and 4Sight. Taxonomy3 is a novel in silico platform technology that utilizes proprietary ground-breaking mathematical algorithms to perform complex multivariate analysis of genetic data. Conformetrix enables rational, accelerated 4D structural drug design using experimental data rather than theoretical data. The 4Sight allows its research scientists to view, understand and interrogate the complex, multidimensional molecular shape data of drug molecules.

C4X Discovery Holdings (FRA:C4J) Headlines

No Headlines